• 1
    Williams HE. Oxalic acid and hyperoxaluric syndromes. Kidney Int 1978; 13: 410417.
  • 2
    Salyer WR, Keren D. Oxalosis as a complication of renal failure. Kidney Int 1973; 4: 6166.
  • 3
    Zarembski PM, Hodgkinson A. Elevation of the concentration of plasma oxalic acid in renal failure. Nature 1966; 212: 511512.
  • 4
    Petrarulo M, Cerelli E, Marangella M, Cosseddu D, Vitale C, Linari F. Assay of plasma oxalate with soluble oxalate oxidase. Clin Chem 1994; 40: 20302034.
  • 5
    Worcester EM, Fellner SK, Nakagawa Y, Coe FL. Effect of renal transplantation on serum oxalate and urinary oxalate excretion. Nephron 1994; 67: 414418.
  • 6
    Hoppe B, Kemper MJ, Bökemkamp A, Portale AA, Cohn RA, Langman CB. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end stage-renal failure. Kidney Int 1999; 56: 268274.DOI: 10.1046/j.1523-1755.1999.00546.x
  • 7
    McConnell KN, Rolton HA, Modi KS, Macdougall AI. Plasma oxalate in patients with chronic renal failure receiving continuous ambulatory peritoneal dialysis or hemodialysis. Am J Kidney Dis 1991; 18: 441445.
  • 8
    Fayemi AO, Ali M, Braun EV. Oxalosis in hemodialysis patients. Arch Pathol Lab Med 1979; 103: 5862.
  • 9
    Hoppe B, Kemper MJ, Bökemkamp A, Portale AA, Cohn RA, Langman CB. Plasma calcium oxalate supersaturation in children with renal insufficiency and with primary hyperoxaluria. Kidney Int 1998; 54: 921925.DOI: 10.1046/j.1523-1755.1998.00066.x
  • 10
    Fansworth A, Horvath JS, Hall BM et al. Renal biopsy morphology in renal transplantation. A comparative study of the light-microscopic appearances of biopsies from patients treated with cyclosporine A or azathioprine prednisone and antilymphocyte globulin. Am J Surg Pathol 1984; 8: 243252.
  • 11
    Olsen S, Burdick JF, Keown PA, Wallace AC, Racusen LC, Solez K. Primary acute renal failure (“Acute Tubular Necrosis”) in the transplanted kidney: morphology and pathogenesis. Medicine 1989; 68: 173187.
  • 12
    Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378383.DOI: 10.1111/j.1600-6143.2004.00332.x
  • 13
    Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002; 62: 311318.DOI: 10.1046/j.1523-1755.2002.00424.x
  • 14
    Siddiqi N, Mc Bride MA, Hariharan S. Similar profiles for post-transplant renal dysfunction and long term graft failure: UNOS/OPTN database analysis. Kidney Int 2004; 65: 19061913.DOI: 10.1111/j.1523-1755.2004.00589.x
  • 15
    Bergstrand A, Collste LG, Franksson C et al. Oxalosis in renal transplants following methoxyflurane anaesthesia. Br J Anaesth 1972; 44: 569574.
  • 16
    Scheinman JI, Najarian JS, Mauer SM. Successful strategies for renal transplantation in primary oxalosis. Kidney Int 1984; 25: 804811.
  • 17
    Chaplin AJ. Histopathological occurrence and characterization of Calcium oxalate: a review. J Clin Pathol 1977;30: 800811.
  • 18
    Worcester EM, Nakagawa Y, Bushinsky DA, Coe FL. Evidence that serum Calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure. J Clin Invest 1986; 77: 18881896.
  • 19
    Morgan SH, Purkiss RWE, Mansell MA. Oxalate dynamics in chronic renal failure. Comparison with normal subjects and patients with Primary Hyperoxaluria. Nephron 1987; 46: 253257.
  • 20
    Fayemi AO, Ali M, Braun EV. Oxalosis in hemodialysis patients. Arch Pathol Lab Med 1979; 103: 5862.
  • 21
    Watts RWE. Treatment of Primary Hyperoxaluria type I. J Nephrol 1994; 7: 208214.
  • 22
    Solez K, Racusen LC, Marcussen N, Slatnik I, Keown P, Olsen S. Morphology of ischemic acute renal failure, normal function and cyclosporine toxicity in cyclosporine-treated renal allograft recipients Kidney Int 1993; 43: 10581067
  • 23
    Fayemi AO, Ali M. The pathology study of end-stage renal disease in hemodialysis patients. Isr J Med Sci 1979; 15: 901909.
  • 24
    Op de Hoek, CT, Diderich PNM, Gratama S, Weijs-Hofwegen EJM. Oxalosis in chronic renal failure. Proc Eur Dial Transplant Assoc 1980; 17: 730735.
  • 25
    Hoppe B, Graft D, Offner G et al. Oxalate elimination via hemodialysis or peritoneal dialysis in children with chronic renal failure. Kidney Int 1996; 10: 488492.
  • 26
    Khan SR, Shevock PN, Hackett RL. Acute hyperoxaluria, renal injury and Calcium oxalate urolithiasis. J Urol 1992; 147: 226230.
  • 27
    Khan SR, Hackett RL. Hyperoxaluria, enzymuria and nephrolithiasis. Contrib Nephrol 1993; 101: 190193.
  • 28
    Muthukumar A, Selvam R. Renal injury mediated calcium oxalate nephrolithiasis: role of lipid peroxidation. Ren Fail 1997;19: 401408.
  • 29
    Huang HS, Ma MC, Chen CF, Chen J. Lipid peroxidation and its correlation with urinary levels of oxalate. Citric acid, and osteopontin in patients with renal calcium oxalate stones. Urology 2003; 62: 11231128.DOI: 10.1016/S0090-4295(03)00764-7
  • 30
    Scheid C, Koul H, Hill WA et al. Oxalate toxicity in LLC-PK1 cells: role of free radicals. Kidney Int 1996; 49: 413419.
  • 31
    Koul S, Fu S, Koul H. Oxalate exposure promotes reinitiation of DNA synthesis and apoptosis of HK-2 cells, a line of human epithelial cells. Ann N Y Acad Sci 2003; 1010: 292295.DOI: 10.1196/annals.1299.050
  • 32
    Lieske JC, Walsh-Reitz MM, Toback G. Calcium oxalate monohydrated crystals are endocytosed by renal epithelial cells and induce proliferation. Am Physiol Soc 1992; 262: 622630.
  • 33
    Hammes MS, Lieske JC, Pawar S, Spargo B, Toback FG. Calcium oxalate monohydrated crystals stimulate gene expression in renal epithelial cells. Kidney Int 1995; 48: 501509.
  • 34
    Koul H, Kennington L, Nair G, Honeyman T, Menon M, Scheid C. Oxalate-induced initiation of DNA synthesis in LLC-Pk1 cells, a line of renal epithelial cells. Biochem Biophys Res Comm 1994; 205: 16321637.DOI: 10.1006/bbrc.1994.2854
  • 35
    Koul HK. Role of p38 MAP kinase signal transduction in apoptosis and survival of renal epithelial cells. Ann N Y Acad Sci 2003; 1010: 6265.DOI: 10.1196/annals.1299.008
  • 36
    Paul LC. Chronic allograft nephropathy—a model of impaired repair from injury. Nephrol Dial Transplant 2000; 15: 149151.DOI: 10.1093/ndt/15.2.149
  • 37
    Racusen L, Solez K, Colvin R. Fibrosis and atrophy in renal allografts: interim repost and new directions. Am J Transplant 2002; 2: 203206.DOI: 10.1034/j.1600-6143.2002.20303.x
  • 38
    Joosten SA, Van Kooten C, Sijpkens YW, De Fijter, JW, Paul LC. The pathobiology of chronic allograft nephropathy: immune-mediated damage and accelerated aging. Kidney Int 2004; 65: 15561559.DOI: 10.1111/j.1523-1755.2004.05410.x
  • 39
    Nankivell BJ, Borrows RJ, Chir B et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 23262333.DOI: 10.1056/NEJMoa020009